| Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally |
| α. Enhancing Drug Efficacy by This Combination |
| Achieving Therapeutic Synergy |
Click to Show/Hide |
| Experiment 1 Reporting the Effect of This Combination |
[1] |
| In-vitro Model |
Staphylococcus aureus |
Microorganism model |
Staphylococcus aureus |
| Streptococcus pyogenes |
Microorganism model |
Streptococcus pyogenes |
| Escherichia coli |
Microorganism model |
Escherichia coli |
| Salmonella enterica serovar Typhi |
Microorganism model |
Salmonella enterica |
| Shigella species |
Microorganism model |
Shigella |
| Salmonella Paratyphi A |
Microorganism model |
Salmonella Paratyphi |
| Pseudomonas aeuginosa |
Microorganism model |
Pseudomonas aeruginosa |
| Acinetobacter baumannii |
Microorganism model |
Acinetobacter baumannii |
| Klebseilla pneumoniae |
Microorganism model |
Klebseilla pneumoniae |
| Citrobacter freuendii |
Microorganism model |
Citrobacter freuendii |
| Enterobacter cloacae |
Microorganism model |
Enterobacter cloacae |
| Bacillus subtilis |
Microorganism model |
Bacillus subtilis |
| Streptococcus pneumoniae |
Microorganism model |
Streptococcus pneumoniae |
| Micrococcus |
Microorganism model |
Micrococcus |
| Helicobacter pylori |
Microorganism model |
Helicobacter pylori |
| Campylobacter jejuni |
Microorganism model |
Campylobacter jejuni |
| Pasteurella multocida |
Microorganism model |
Pasteurella multocida |
Experimental
Result(s) |
When Camellia sinensis was combined with nalidixic acid, it was able to inhibit S. Typhi at sub-MIC levels. |
